Earl F. Albone

Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease

Malcolm C. Roberts, Ioanna Sevastou, Yoichi Imaizumi et al. · Acta Neuropathologica Communications · 2020 · 119 citations · Full text

Bioconjugation by Native Chemical Tagging of C–H Bonds

Qianghui Zhou, Jinghan Gui, Chung‐Mao Pan et al. · Journal of the American Chemical Society · 2013 · 105 citations

MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity

Xin Cheng, Jing Li, Keigo Tanaka et al. · Molecular Cancer Therapeutics · 2018 · 89 citations

Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes

Daniel J. O’Shannessy, Elizabeth B. Somers, Earl F. Albone et al. · Oncotarget · 2011 · 71 citations · Full text

The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity

Jianmin Lin, Jared Spidel, Christopher Maddage et al. · Cancer Biology & Therapy · 2013 · 54 citations · Full text

Cisplatin Sensitivity, Antitumor Activity, Chemoprevention Strategy +19